Cresco Labs Inc (CL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 724,343 | 770,885 | 842,681 | 821,682 | 476,251 |
| Cost of Goods | 359,889 | 408,519 | 435,668 | 415,335 | 192,311 |
| Gross Profit | 364,454 | 362,366 | 407,013 | 406,347 | 283,940 |
| Operating Expenses | 254,372 | 299,486 | 350,081 | 318,557 | 228,099 |
| Operating Income | 110,082 | 62,880 | 56,932 | 87,790 | 55,841 |
| Interest Expense | 58,901 | 63,243 | 58,516 | 52,149 | 40,907 |
| Other Income | -61,797 | -146,539 | -125,321 | -292,368 | -7,776 |
| Pre-tax Income | -10,616 | -146,902 | -126,905 | -256,727 | 7,158 |
| Income Tax | 49,873 | 32,950 | 88,938 | 40,107 | 43,720 |
| Net Income Continuous | -60,489 | -179,852 | -215,843 | -296,834 | -36,562 |
| Minority Interests | -13,949 | 4,330 | 3,796 | -22,763 | -45,363 |
| Net Income | $-74,438 | $-175,522 | $-212,047 | $-319,597 | $-81,925 |
| EPS Basic Total Ops | -0.22 | -0.54 | -0.71 | -1.22 | -0.39 |
| EPS Basic Continuous Ops | -0.22 | -0.54 | -0.71 | -1.22 | -0.39 |
| EPS Diluted Total Ops | -0.22 | -0.54 | -0.71 | -1.22 | -0.39 |
| EPS Diluted Continuous Ops | -0.22 | -0.54 | -0.71 | -1.22 | -0.39 |
| EBITDA(a) | $114,278 | $-14,355 | $-10,664 | $-159,629 | $88,084 |